טוען...
CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
AIMS: We hypothesised that CD1d expression in renal cell carcinoma (RCC) may play a role in modifying the host immune response. Our aims were to investigate the expression of CD1d and to correlate this with histopathology and clinical outcomes in a cohort study of patients with RCC. METHODS: Gene ex...
שמור ב:
| הוצא לאור ב: | J Clin Pathol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4345982/ https://ncbi.nlm.nih.gov/pubmed/25477528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jclinpath-2014-202735 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|